Novavax, Inc (NASDAQ: NVAX) is -41.62% lower on its value in year-to-date trading and has touched a low of $5.01 and a high of $17.81 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVAX stock was last observed hovering at around $6.84 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $6.97, the stock is 4.51% and 2.71% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.73 million and changing 1.90% at the moment leaves the stock -15.44% off its SMA200. NVAX registered -13.31% loss for a year compared to 6-month loss of -27.43%. The firm has a 50-day simple moving average (SMA 50) of $6.7864 and a 200-day simple moving average (SMA200) of $8.2433.
The stock witnessed a -1.69% gain in the last 1 month and extending the period to 3 months gives it a 28.36%, and is 5.45% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.12% over the week and 4.41% over the month.
Novavax, Inc (NVAX) has around 952 employees, a market worth around $1.13B and $1.25B in sales. Current P/E ratio is 2.63 and Fwd P/E is 30.71. Profit margin for the company is 38.14%. Distance from 52-week low is 39.12% and -60.86% from its 52-week high. The company has generated returns on investments over the last 12 months (324.46%).
with sales reaching $147.55M over the same period.The EPS is expected to grow by 298.25% this year, but quarterly earnings will post 49.94% year-over-year. Quarterly sales are estimated to shrink -64.49% in year-over-year returns.
Novavax, Inc (NVAX) Top Institutional Holders
319.0 institutions hold shares in Novavax, Inc (NVAX), with institutional investors hold 62.70% of the company’s shares. The shares outstanding are 161.96M, and float is at 147.54M with Short Float at 31.56%. Institutions hold 57.19% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.08 million shares valued at $178.19 million. The investor’s holdings represent 9.4861% of the NVAX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.85 million shares valued at $149.98 million to account for 7.984 of the shares outstanding. The other top investors are SHAH CAPITAL MANAGEMENT which holds 9.66 million shares representing 6.5118% and valued at over $122.32 million, while D. E. SHAW & CO., INC. holds 4.2608 of the shares totaling 6.32 million with a market value of $80.04 million.
Novavax, Inc (NVAX) Insider Activity
#####
Still, SEC filings show that on Dec 13 ’24, King Rachel K. (Director) disposed off 4,150 shares at an average price of $9.02 for $37435.0. The insider now directly holds 14,770 shares of Novavax, Inc (NVAX).